08/01/2025  21:55:32 Diferencia -1.800 Volumen Bid21:58:00 Ask21:58:00 Capitalización de mecado Dividendo A. P/E Ratio
143.850EUR -1.24% 5,932
Volumen de negocios: 853,903.850
142.300Volumen de oferta: 100 143.850Tamaño/ Volumen/ Formato de Ask: 100 18.49 mil millonesEUR 1.54% 22.04

Descripción de negocio

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
 

Consejo de gestión & Consejo de supervisión

CEO
Belén Garijo
Consejo de gestión
Helene von Roeder, Dr. Kai Beckmann, Matthias Heinzel, Peter Guenter
Consejo de supervisión
Michael Kleinemeier, Sascha Held, Anne Lange, Dietmar Oeter, Simon Thelen, Birgit Biermann, Katja Garcia Vila, Carla Kriwet, Barbara Lambert, Stefan Palzer, Alexander Putz, Christian Raabe, Michael Reinhart, Susanne Schaffert, Sandra Schwebke, Daniel Thelen
 

Datos de la empresa

Nombre: Merck KGaA
Dirección: Frankfurter Str. 250,D-64293 Darmstadt
Teléfono: +49-6151-72-0
Fax: +49-6151-72-2000
E-mail: service@merckgroup.com
Internet: www.merck.de
Industria: Healthcare
Sector: Pharmaceutical Industry
Subsector: Pharmaceuticals
Fin del año financiero: 31/12
Acciones de libre circulación: 66.28%
Fecha de OPI: 20/10/1995

Relación con inversores

Nombre: Constantin Fest
IR teléfono: +49-6151-72-3321
IR-fax: +49-6151-72-91-3321
IR e-mail: investor.relations@m...oup.com investor.relations@merckgroup.com

Calendario de la empresa

CW 10 | 06/03/2025 Annual Report
CW 17 | 25/04/2025 General Shareholder Meeting
CW 20 | 15/05/2025 Interim Report 1st Quarter/3 Months
CW 32 | 07/08/2025 Interim Report 2nd Quarter/6 Months
CW 46 | 13/11/2025 Interim Report 3rd Quarter/9 Months
 

Accionistas mayoritarios

Otros
 
73.64%
BlackRock, Inc.
 
7.43%
Massachusetts Financial Services Company
 
5.06%
Sun Life Financial Inc.
 
4.91%
FMR LLC
 
3.02%
Amundi S.A.
 
2.99%
DWS Investment GmbH
 
2.95%